Clinical Trial Update: Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer; status shows ACTIVE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Ovarian Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING